Page last updated: 2024-09-05

bms204352 and letrozole

bms204352 has been researched along with letrozole in 2 studies

Compound Research Comparison

Studies
(bms204352)
Trials
(bms204352)
Recent Studies (post-2010)
(bms204352)
Studies
(letrozole)
Trials
(letrozole)
Recent Studies (post-2010) (letrozole)
491122,6126121,602

Protein Interaction Comparison

ProteinTaxonomybms204352 (IC50)letrozole (IC50)
Steryl-sulfataseHomo sapiens (human)0.0009
AromataseHomo sapiens (human)0.009
Cytochrome P450 11B1, mitochondrialHomo sapiens (human)2.62
Cytochrome P450 11B2, mitochondrialHomo sapiens (human)1.42
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)0.0009

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

2 other study(ies) available for bms204352 and letrozole

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013